Increased natural killer resistance to cyclosporine A by continuous doses of dexamethasone in rats (original) (raw)

Abstract

There is a controversy on the effects of physiological levels of glucocorticoids on natural killer (NK) cytotoxity. Therefore, the effects of exogenously administered dexamethasone on NK cytotoxity in 8-week-old male, Fischer 344 rats were studied. We suppose that the reason for the controversy is insufficient sensitivity of the ordinal radioactive chromium-release assay for normal healthy subjects or animals. Therefore, we developed a new index, a resistance to artificial immunosuppressor, cyclosporine A (CsA) using rat NK activity as an indicator, and named this index, increased resistance to immunosuppressor (IRIS). After some basic, characterizing studies, authors confirmed the fact that continuous doses of dexamethasone (DEX) attenuated NK suppression of CsA. In protocol 4, 18 rats were randomly divided into three groups: the first (DEX +CsA) was injected for 5 days with 0'1 mg DEX/kg/day and a single dose of CsA on the final day, intraperitoneally; the second (SAL+CsA) was treated with an equal volume of saline and CsA; the third (DEX +SAL) was treated with DEX but not CsA. The IRIS in NK activity was increased significantly (P<0-01) with 5 days injection of DEX. These results demonstrated that physiological, and continuous dosage of glucocorticoids stimulated IRIS in NK activity in rats, and this suggests that appropriate stimuli through the hypothalamic-adrenal axis might be acting, at least, as a defence against immune collapses or dysfunctions.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (16)

  1. FAUCi A.S., DALE D.C. & BALow J.E. (1976) Glucocorticosteroid therapy: Mechanisms of action and clinical considerations. Ann Intern Med 84, 304.
  2. ADER R., FELTEN D. & CoHEN N. (1990) Interactions between the brain and the immune system. Annu Rev Pharmacol Toxicol 30, 561.
  3. BAXTER J.D. & FORSHAM H. (1972) Tissue effects of glucocortico- ids. Am J Med 53, 573. chronic treatment with the glucocorticoid antagonist RU 486 in man: toxicity, immunological, and hormonal aspects. J Clin Endocrinol Metab 71, 1474.
  4. FERY B.M., WALKER C., FREY F.J. & WECK A.L. (1984) Pharmacokinetics and pharmacodynamics of three different prednisolone prodrugs: effect on circulating lymphocyte subsets and function. J Immunol 133, 2479.
  5. MUNCK A., GuyrRE P.M. & HOLBROOK N.J. (1984) Physiological functions of glucocorticoids in stress and their relation to pharma- cological actions. Endocr Rev 5, 25.
  6. PEDERSEN B.K. (1985) Natural killer cells in relation to disease and treatment. A review. Allergy 40, 547.
  7. NISsOKA K., SHIMADA K. & MASAKI T. (1984) Useful Assaysfor Immune Experiment. Koudanshya Scientific, Tokyo (in Japanese).
  8. Lozzio C.B. & Lozzio B.B. (1975) Human chronic mylogenous leukemia cell-line with positive philadelphia chromosome. Blood 45, 321.
  9. IcIHmARAK. (1990) Statisticsfor Biosciences -Practical Technique and Theory. Nankodo, Tokyo (in Japanese).
  10. HOFFMAN-GOETZ L., THORNE R.J. & HOUSTON M.E. (1988) Splenic immune responses following exercise in mice. Can J Physiol Pharmacol 66, 1415.
  11. HERBERMAN R.B. (1981) Natural killer (NK) cells and their possible roles in resistance against disease. Clin Immunol Rev 1, 1.
  12. SCHREIBER S.L. & CABTRam G.R. & CRABTnEn G.R. (1992) The mechanism of action of cyclosporin A and FK506. Immunol Today 13, 136.
  13. HENNEY C.S., KURIBAYASHI K., KERN D.E. & GILLIS S. (1981) Interleukin-2 augments natural killer cell activity. Nature 291, 335.
  14. ELLIOT J. F. LIN Y., MIZEL S.B., BLEACKLEY R.C., HARNISH D.G. & PAETKAu V. (1984) Induction of interleukin 2 messenger RNA inhibited by Cyclosporin A. Science 226, 1439.
  15. GOODWIN J.S., ATLURU D., SImRAKowsKI S. & LIANos E.A. (1986) Mechanism of action of glucocorticoids: Inhibition of T cell proliferation and interleukin 2 production by hydrocortisone is reversed by leukotriene B Clin Invest 77, 1244.
  16. C 1997 Blackwell Science Ltd, Immunology, 92, 407-411